Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Operations (Unaudited)

v3.20.1
Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Income Statement [Abstract]    
Revenues $ 1,016,776 $ 1,324,240
Cost of Sales (376,816) (559,319)
Gross Profit 639,960 764,921
Operating Expenses    
Salaries and related costs 1,224,353 1,532,789
Other general and administrative 1,230,135 1,487,720
Research and development 750,000
Advertising 144,618 1,135,546
Depreciation and amortization 22,108 211,218
Total Operating Expenses 3,371,214 4,367,273
Operating Loss (2,731,254) (3,602,352)
Other Income (Expense)    
Other income (expense) 2,538 (205)
Interest expense (56,149) (92,259)
Change in fair value of redemption put liability 193,659
Change in fair value of derivative liability - warrants 174,978
Total Other Income (Expense) 315,026 (92,464)
Net Loss (2,416,228) (3,694,816)
Accrued dividends on outstanding Series B Convertible Preferred Stock 18,300 24,639
Deemed dividend on adjustment to exercise price on certain warrants 404,384
Deemed dividend on Series D Convertible Preferred Stock 158,147
Deemed dividend on Beneficial Conversion Features 32,592
Net loss attributable to common stockholders $ (2,592,675) $ (4,156,431)
Loss per share - Basic and Diluted $ (0.03) $ (0.05)
Weighted average outstanding shares - basic and diluted 99,839,617 85,513,024